Graduate Program in Medical Sciences, Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brazil.
Cytokine. 2012 Nov;60(2):473-7. doi: 10.1016/j.cyto.2012.05.026. Epub 2012 Jul 3.
A previous study suggested that the CXCR2 (+1208) TT genotype was associated with increased risk of systemic sclerosis (SSc). In the present study, we investigated the influence of variation in the CXCL8 and CXCR2 genes on susceptibility to SSc and combined the variant alleles of these genes to analyze their effects on SSc.
One fifty one patients with SSc and 147 healthy bone marrow donors were enrolled in a case-control study. Blood was collected for DNA extraction; typing of CXCL8 (-251) T/A and CXCR2 (+1208) T/C genes was made by polymerase chain reaction with sequence specific primers (PCR-SSP), followed by agarose gel electrophoresis.
The CXCR2-TC genotype was significantly less frequent in patients (23.8% versus 55.1% in controls; P<0.001, OR=0.26, 95%CI=0.15-0.43), whereas the CXCR2-CC genotype was significantly more frequent (44.4% versus 22.4% in controls; P<0.001, OR=2.76, 95%CI, 1.62-4.72). When CXCR2 and CXCL8 combinations were analyzed, the presence of CXCR2 T in the absence of CXCL8 A (CXCR2 T+/CXCL8 A-) was more frequent in patients than in controls (34.5% versus 3.5%; P<0.001, OR=14.50, 95%CI=5.04-41.40). However, CXCR2 TT and CXCL8 A were significantly more common in controls (100%) than in patients (58.3%) (P<0.001). Likewise, the presence of CXCR2 TC and CXCL8 A was more frequent in controls (95.1%) than in patients (75%) (P=0.004). Furthermore, the CXCR2-CC genotype in CXCL8 A was more frequent in patients (59.7% versus 0% in controls; P<0.001, adjusted OR=98.67, 95%CI=6.04-1610.8). In patients, a high frequency was observed in combination with the CXCL8 TA and AA genotypes (P<0.001; OR=28.92), whereas in controls, there was a high frequency of combination with CXCL8 T (P<0.001; OR=0.03) and TT (P<0.001; OR=0.01).
These findings suggest a protective role of CXCL8 (-251) A in the CXCR2 (+1208) TT and TC genotypes and an increased risk of CXCL8 (-251) A in association with the CXCR2 (+1208) CC genotype in SSc patients.
先前的研究表明,CXCR2(+1208)TT 基因型与系统性硬化症(SSc)的发病风险增加相关。本研究旨在探讨 CXCL8 和 CXCR2 基因的变异对 SSc 易感性的影响,并对这些基因的变异等位基因进行组合分析,以研究其对 SSc 的影响。
151 例 SSc 患者和 147 例健康骨髓供者纳入病例对照研究。采集血液用于 DNA 提取;采用聚合酶链反应序列特异性引物(PCR-SSP)对 CXCL8(-251)T/A 和 CXCR2(+1208)T/C 基因进行分型,然后进行琼脂糖凝胶电泳。
CXCR2-TC 基因型在患者中明显较少(23.8%比对照组的 55.1%;P<0.001,OR=0.26,95%CI=0.15-0.43),而 CXCR2-CC 基因型在患者中明显较多(44.4%比对照组的 22.4%;P<0.001,OR=2.76,95%CI,1.62-4.72)。分析 CXCR2 和 CXCL8 组合时,CXCR2 无 CXCL8 A(CXCR2 T+/CXCL8 A-)的存在在患者中比对照组更为常见(34.5%比 3.5%;P<0.001,OR=14.50,95%CI=5.04-41.40)。然而,CXCR2 TT 和 CXCL8 A 在对照组中更为常见(100%比患者中 58.3%)(P<0.001)。同样,CXCR2 TC 和 CXCL8 A 在对照组中更为常见(95.1%比患者中 75%)(P=0.004)。此外,CXCL8 A 中的 CXCR2-CC 基因型在患者中更为常见(59.7%比对照组的 0%;P<0.001,调整后的 OR=98.67,95%CI=6.04-1610.8)。在患者中,与 CXCL8 TA 和 AA 基因型联合观察到高频率(P<0.001;OR=28.92),而在对照组中,与 CXCL8 T 联合观察到高频率(P<0.001;OR=0.03)和 TT(P<0.001;OR=0.01)。
这些发现表明,在 SSc 患者中,CXCL8(-251)A 在 CXCR2(+1208)TT 和 TC 基因型中具有保护作用,而在 CXCR2(+1208)CC 基因型中,CXCL8(-251)A 的风险增加。